Altimmune, inc. reports impairment charges for the quarter ended september 30, 2019

Altimmune, inc. reported impairment charges for the quarter ended september 30, 2019. impairment charges was $1,000,000 related to its sparvax-l program.
ALT Ratings Summary
ALT Quant Ranking